Characteristics and treatment patterns of patients with advanced or metastatic non-small cell lung cancer managed with first-line immuno-oncology strategies in Greece: Interim results of a real-world prospective study (IO-HORIZON)

被引：0

作者：

Linardou, H. ^{[1
,2
]}

Charpidou, A. ^{[3
]}

Koumarianou, A. ^{[4
]}

Mountzios, G. ^{[5
,6
]}

Kosmidis, P. A. ^{[7
]}

Christodoulou, C. ^{[8
]}

Mavroudis, D. ^{[9
]}

Christopoulou, A. N. ^{[10
]}

Korantzis, I. ^{[11
]}

Baka, S. ^{[12
]}

Vaslamatzis, M. ^{[13
]}

Athanasiadis, I. ^{[14
]}

Koutras, A. ^{[15
]}

Mauri, D. ^{[16
]}

Kotsakis, A. ^{[17
]}

Ziogas, D. ^{[18
]}

Desiniotis, A. ^{[19
]}

Dimitriadis, I. ^{[19
]}

Syrigos, K. ^{[2
]}

机构：

[1] Metropolitan Hosp, Oncol Dept 4, Athens, Greece

[2] Metropolitan Hosp, Comprehens Clin Trials Ctr, Athens, Greece

[3] Natl & Kapodistrian Univ Athens, Sotiria Hosp Dis Chest, Dept Med 3, Oncol Unit, Athens, Greece

[4] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 4, Hematol Oncol Unit, Haidari, Greece

[5] Henry Dunant Hosp Ctr, Dept Med Oncol 4, Athens, Greece

[6] Henry Dunant Hosp Ctr, Clin Trials Unit, Athens, Greece

[7] Hygeia Hosp, Dept Med Oncol 2, Maroussi, Greece

[8] Metropolitan Hosp, Dept Med Oncol 2, Athens, Greece

[9] Univ Gen Hosp Herakl, Dept Med Oncol, Iraklion, Greece

[10] St Andrew Hosp, Med Oncol Unit, Patras, Greece

[11] St Lukes Hosp, Dept Oncol, Agios Loukas Clin, Thessaloniki, Greece

[12] Interbalkan European Med Ctr, Dept Oncol, Thessaloniki, Greece

[13] Evangelismos Gen Hosp Athens, Athens, Greece

[14] Mitera Hosp, Dept Med Oncol, Maroussi, Greece

[15] Univ Hosp Patras, Dept Med, Div Oncol, Patras, Greece

[16] Univ Hosp Ioannina, Dept Med Oncol, Ioannina, Greece

[17] Univ Hosp Larissa, Dept Med Oncol, Larisa, Greece

[18] Natl & Kapodistrian Univ Athens, Sch Med, Dept Med 1, Athens, Greece

[19] MSD Greece, Athens, Greece

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

48P

引用

页码：S69 / S70

页数：2

共 50 条

[1] Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer
Betts, Keith A.
Gao, Sophie
Ray, Saurabh
Schoenfeld, Adam J.
[J]. FUTURE ONCOLOGY, 2024, 20 (13) : 851 - 862
[2] The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
Low, Jia Li
Walsh, Robert J.
Ang, Yvonne
Chan, Gloria
Soo, Ross A.
[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
[3] Real-world immuno-oncology treatment patterns and outcomes in US patients with metastatic non-small-cell lung cancer.
Bruno, Amanda
Bell, Kelly
Stafkey-Mailey, Dana
Murty, Sharanya
Ballas, Marc S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] Second-line (2L) real-world treatment (tx) patterns and outcomes in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) treated with first-line (1L) immuno-oncology (IO) monotherapy (mono tx)
Talbot, D.
Fish, S. M.
Ong, T. Jin
Flick, E. D.
Waterhouse, D. M.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[5] Real-World (RW) Predictors of Immuno-Oncology (IO) vs Chemotherapy (C) Use in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Radtchenko, J.
Korytowsky, B.
Nwokeji, E.
Tue, K.
Feinberg, B.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S889 - S889
[6] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
Kokkotou, E.
Charpidou, A.
Papaspiliou, A.
Stournara, L.
Grammatikou, V.
Ejzykowicz, F.
Syrigos, K.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
[7] Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
Engel-Nitz, Nicole M.
Johnson, Michael P.
Bunner, Scott H.
Ryan, Kellie J.
[J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (06): : 729 - 740
[8] REAL-WORLD FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN TAIWAN: A POPULATION-BASED RETROSPECTIVE STUDY
Hsia, Te-Chun
Chung, Ching-Hu
[J]. RESPIROLOGY, 2018, 23 : 297 - 298
[9] Real-World Study of Patients With EGFR Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Treated With First-Line Osimertinib
Nieva, J.
Taylor, A.
Servidio, L.
Sun, P.
Okhuoya, P.
Horvat, P.
Tolani, E.
Magee, K.
Mathur, R.
Balakrishna, S.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1113 - S1113
[10] Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
Liam, C.
Ho, G.
Chai, C.
Alip, A. Bt
Pang, Y.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S998 - S999

← 1 2 3 4 5 →